Trial Profile
Combination therapy with a cholinergic receptor antagonist and an alpha-1 adrenergic receptor antagonist in treatment-naive patients with benign prostatic hyperplasia complicated by overactive bladder
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 29 Jun 2016
Price :
$35
*
At a glance
- Drugs Propiverine (Primary) ; Silodosin (Primary)
- Indications Benign prostatic hyperplasia; Overactive bladder
- Focus Therapeutic Use
- 08 Mar 2012 New trial record